Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biological activities of rubidazone.

Literature DB >> 498417

Biological activities of rubidazone.

Abstract

Rubidazone (benzoylhydrazone daunorubicin) is a semisynthetic compound with a good experimental antitumor activity. Its main interest is its lower toxicity and cardiotoxicity. In human chemotherapy, it is considered a valuable drug.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1979 PMID： 498417 DOI： 10.1007/bf00253102

Source DB: PubMed Journal: Cancer Chemother Pharmacol ISSN： 0344-5704 Impact factor: 3.333

14 in total

1. Graft versus host reactions. Their natural history, and applicability as tools of research.

Authors: M SIMONSEN
Journal: Prog Allergy Date: 1962

2. A phase 1 and 2 trial of rubidazone in patients with acute leukemia.

Authors: R S Benjamin; M J Keating; K B McCredie; G P Bodey; E J Freireich
Journal: Cancer Res Date: 1977-12 Impact factor: 12.701

3. An anthracycline antibiotic-induced cardiomyopathy in rabbits.

Authors: R S Jaenke
Journal: Lab Invest Date: 1974-03 Impact factor: 5.662

4. [Antigenic modifications of cancerous cells].

Authors: G Jollès; R Maral
Journal: C R Acad Hebd Seances Acad Sci D Date: 1968-10-07

5. Effect of excision repair system on antibacterial and mutagenic activity of daunomycin and other intercalating agents in Salmonella typhimurium.

Authors: B Pani; C Monti-Bragadin; L Samer
Journal: Experientia Date: 1975-07-15

6. Comparative mammalian metabolism of adriamycin and daunorubicin.

Authors: H Loveless; E Arena; R L Felsted; N R Bachur
Journal: Cancer Res Date: 1978-03 Impact factor: 12.701

7. In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.

Authors: A Mantovani
Journal: Cancer Res Date: 1977-03 Impact factor: 12.701

Review 8. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion.

Authors: J McCann; B N Ames
Journal: Proc Natl Acad Sci U S A Date: 1976-03 Impact factor: 11.205

9. Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies.

Authors: C Jacquillat; M Weil; M F Gemon-Auclerc; V Izrael; A Bussel; M Boiron; J Bernard
Journal: Cancer Date: 1976-02 Impact factor: 6.860